Prevention of myalgia due to succinylcholine using an anti-contracture drug; pyridinolum mesylate (1,1-diphenyl-1-ol-piperidinopropano-methansulfonate
Spingardi, G.; Maggi, C.
Minerva Anestesiologica 44(11): 803-810
1978
ISSN/ISBN: 0375-9393 PMID: 754078 Document Number: 125773
Document emailed within 1 workday
Related Documents
Amornyotin, S.; Santawat, U.; Rachatamukayanant, P.; Nilsuwankosit, P.; Pipatnaraphong, H. 2002: Can lidocaine reduce succinylcholine induced postoperative myalgia? Journal of the Medical Association of Thailand 85(Suppl 3): S969-S974Rubio Pascual, P.; García Molina, C.; López Vicente, J.R.; Madrid Arias, J.L. 1987: Unilateral contracture of the denervated masseter muscle following the administration of succinylcholine: apropos of a case Revista Espanola de Anestesiologia y Reanimacion 34(2): 154-155
Bruno, O.; Ranise, A.; Bondavalli, F.; Schenone, P.; D'Amico, M.; Filippelli, A.; Filippelli, W.; Rossi, F. 1993: 3,5-diphenyl-1H-pyrazole derivatives. XI. N-aryl-5(3)-phenyl-4-(3,5- diphenyl-1-pyrazolyl)-3(5)-pyrazole amines, 5-substituted 4,5-dihydro-3-phenyl-4-(3,5-diphenyl-1-pyrazolyl)-1H-pyrazoles and 2,6-disubstituted 1,6-dihydro-4- phenyl-5-(3,5-diphenyl-1-pyrazolyl)pyrimidines with antipyretic, antiinflammatory and other activities Farmaco 48(7): 949-966
Wynn, R.L. 2009: Phentolamine mesylate--an old medical drug becomes a new dental drug General Dentistry 57(3): 200-202
Kendig, J.J.; Bunker, J.P.; Endow, S. 1972: Succinylcholine-induced hyperkalemia: effects of succinylcholine on resting potentials and electrolyte distributions in normal and denervated muscle Anesthesiology 36(2): 132-137
Ranise, A.; Bruno, O.; Schenone, S.; Bondavalli, F.; Falcone, G.; Filippelli, W.; Sorrentino, S. 1997: Synthesis of 6-thiosubstituted 5-ethoxycarbonyl-1,3-diphenyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-ones, 6-substituted 5-hydroxy-1,3-diphenyl-2,3-dihydrothieno[2,3-d]pyrimidin-4(1H)-ones and their esters with local anesthetic, antiarrhythmic, antiinflammatory and analgesic activities Farmaco 52(8-9): 547-555
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19
Plötz, J. 1993: Prevention of succinylcholine-induced undesirable effects Klinische Anasthesiologie und Intensivtherapie 42: 117-131
Börner, P.; Deicher, H.; Ghani, G.; Geldmacher, H.; Kayser, D.; Kahnt, P.; Klang, D.; Klaus, H.; Marks, V.; Nehawandian, O.A. 1971: Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion Geburtshilfe und Frauenheilkunde 31(10): 911-923
Scheinfeld, N. 2006: Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate Journal of Drugs in Dermatology: Jdd 5(3): 228-231
2017: Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications Zhonghua nei ke za zhi 56(1): 81-85
Küttel, S.; Rácz, I.; Korbonits, D. 1982: In vitro resorption study of a new anti-arrhythmia compound, N-(3,3-diphenyl-propyl)-N'-(1-phenyl-2-propyl)1,3-propylene diamine dihydrochloride Acta Pharmaceutica Hungarica 52(2): 81-90
Julliard, F.A. 1977: Prevention and treatment of recurrences in Dupuytren's contracture Annales de Chirurgie 31(12): 1047-1051
Agrawal, N.M.; Roth, S.; Graham, D.Y.; White, R.H.; Germain, B.; Brown, J.A.; Stromatt, S.C. 1991: Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial Annals of Internal Medicine 115(3): 195-200
Zlydnikov, D.M. 1980: Prevention of pneumonia in influenza A by means of a new anti-influenza drug rimantadine Terapevticheskii Arkhiv 52(3): 68-71
Simon, B.; Leucht, U.; Amon, I.; Brandau, J.; Müller, P. 1993: Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients Zeitschrift für Gastroenterologie 31(6): 395-400
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Liu, N.F.; Yang, S.A.; Zhong, J. 2000: The pathogenic mechanism and prevention and treatment of muscle contracture after replantation of severed palm or wrist Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 14(1): 27-28
Gaetani, M.; Debeus, R.; Vidi, A.; Coppi, G. 1972: Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. a comparative study of short-term toxicity of DA 2370 and other non-steroid anti-inflammatory drugs (phenylbutazone, mefenamic acid, indometacin and benzydamine) in the rat Arzneimittel-Forschung 22(Suppl 1a): 226-223
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168